Hookipa Biotech's Series C Round

Hookipa Biotech raised a round of funding on December 11, 2017.

Hookipa Biotech is a clinical stage company developing next-generation immunotherapies for infectious diseases and cancer using novel proprietary arenavirus vector platforms.…

Articles about Hookipa Biotech's Series C Round: